{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:47:36Z","timestamp":1785844056634,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.repbio.2026.101187","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:18:41Z","timestamp":1773065921000},"page":"101187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Silencing fatty acid binding protein 5 inhibits prostaglandin E2 and activates CD8 T cells in castration-resistant prostate cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Jun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.repbio.2026.101187_bib1","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity\u2014United States, 2001-2017","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.repbio.2026.101187_bib2","series-title":"Prostate Cancer","first-page":"2021","article-title":"The epidemiology of prostate cancer","author":"Giona","year":"2021"},{"issue":"10","key":"10.1016\/j.repbio.2026.101187_bib3","article-title":"Prostate cancer: a review of genetics, current biomarkers and personalised treatments","volume":"7","author":"Wilson","year":"2024","journal-title":"Cancer Rep"},{"issue":"12","key":"10.1016\/j.repbio.2026.101187_bib4","doi-asserted-by":"crossref","first-page":"a030361","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.repbio.2026.101187_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"19","key":"10.1016\/j.repbio.2026.101187_bib6","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-23-0285","article-title":"Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis","volume":"83","author":"Sun","year":"2023","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.repbio.2026.101187_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.eururo.2021.12.039","article-title":"Pre-existing castration-resistant prostate cancer-like cells in primary prostate cancer promote resistance to hormonal therapy","volume":"81","author":"Cheng","year":"2022","journal-title":"Eur Urol"},{"issue":"27","key":"10.1016\/j.repbio.2026.101187_bib8","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1038\/s41388-021-01874-7","article-title":"Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone","volume":"40","author":"Pan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.repbio.2026.101187_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2024.1611586","article-title":"Spatial distribution of tumor-associated macrophages in an orthotopic prostate cancer mouse model","volume":"30","author":"Grayson","year":"2024","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.repbio.2026.101187_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/17562872231182219","article-title":"Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer","volume":"15","author":"Zarrabi","year":"2023","journal-title":"Ther Adv Urol"},{"issue":"12","key":"10.1016\/j.repbio.2026.101187_bib11","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1073\/pnas.1913940117","article-title":"CD29 identifies IFN-\u03b3-producing human CD8(+) T cells with an increased cytotoxic potential","volume":"117","author":"Nicolet","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.repbio.2026.101187_bib12","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/ijms23031833","article-title":"Granzymes: the molecular executors of immune-mediated cytotoxicity","volume":"23","author":"Hay","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.repbio.2026.101187_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13668","article-title":"Faster cytotoxicity with age: increased perforin and granzyme levels in cytotoxic CD8(+) T cells boost cancer cell elimination","volume":"21","author":"Z\u00f6phel","year":"2022","journal-title":"Aging Cell"},{"issue":"18","key":"10.1016\/j.repbio.2026.101187_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305724","article-title":"Integration analysis of single-cell multi-omics reveals prostate cancer heterogeneity","volume":"11","author":"Bian","year":"2024","journal-title":"Adv Sci"},{"issue":"15","key":"10.1016\/j.repbio.2026.101187_bib15","doi-asserted-by":"crossref","first-page":"16405","DOI":"10.1002\/cam4.6275","article-title":"Prostate cancer cells synergistically defend against CD8(+) T cells by secreting exosomal PD-L1","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med"},{"issue":"33","key":"10.1016\/j.repbio.2026.101187_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2402903121","article-title":"Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization","volume":"121","author":"Yu","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt B","key":"10.1016\/j.repbio.2026.101187_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mce.2017.02.002","article-title":"The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5","volume":"462","author":"Guaita-Esteruelas","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.repbio.2026.101187_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/cancers16010060","article-title":"FABP5 inhibition against PTEN-mutant therapy resistant prostate cancer","volume":"16","author":"Swamynathan","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.repbio.2026.101187_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/BJ20150926","article-title":"The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis","volume":"473","author":"Kawaguchi","year":"2016","journal-title":"Biochem J"},{"issue":"9","key":"10.1016\/j.repbio.2026.101187_bib20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bbalip.2018.06.010","article-title":"Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-\u03baB) signaling in cancer cells","volume":"1863","author":"Senga","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"10.1016\/j.repbio.2026.101187_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pros.23921","article-title":"Docetaxel\/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth","volume":"80","author":"Carbonetti","year":"2020","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.repbio.2026.101187_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s42255-024-01019-6","article-title":"Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring","volume":"6","author":"Sun","year":"2024","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.repbio.2026.101187_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2085432","article-title":"Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"issue":"8011","key":"10.1016\/j.repbio.2026.101187_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","article-title":"PGE(2) limits effector expansion of tumour-infiltrating stem-like CD8(+) T cells","volume":"629","author":"Lacher","year":"2024","journal-title":"Nature"},{"issue":"8011","key":"10.1016\/j.repbio.2026.101187_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE(2) inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.repbio.2026.101187_bib26","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1074\/jbc.RA118.001593","article-title":"Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation","volume":"293","author":"Bogdan","year":"2018","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.repbio.2026.101187_bib27","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.7150\/ijbs.99716","article-title":"Tumor ABCC4-mediated release of PGE2 induces CD8(+) T cell dysfunction and impairs PD-1 blockade in prostate cancer","volume":"20","author":"Li","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.repbio.2026.101187_bib28","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/s41467-021-22173-5","article-title":"The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation","volume":"12","author":"Shang","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.repbio.2026.101187_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s43556-024-00228-5","article-title":"Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8(+) T cell activity in prostate cancer","volume":"5","author":"Liu","year":"2024","journal-title":"Mol Biomed"},{"issue":"1","key":"10.1016\/j.repbio.2026.101187_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s42003-020-01367-5","article-title":"Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells","volume":"3","author":"Seo","year":"2020","journal-title":"Commun Biol"},{"issue":"7","key":"10.1016\/j.repbio.2026.101187_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18212","article-title":"SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation","volume":"28","author":"He","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"3-4","key":"10.1016\/j.repbio.2026.101187_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.18632\/genesandcancer.192","article-title":"Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPAR\u03b3","volume":"10","author":"Al-Jameel","year":"2019","journal-title":"Genes Cancer"},{"issue":"Pt 2","key":"10.1016\/j.repbio.2026.101187_bib33","article-title":"Selective activation of IFN\u03b3-ipilimumab enhances the therapeutic effect and safety of ipilimumab","volume":"265","author":"Huang","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.repbio.2026.101187_bib34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.repbio.2026.101187_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.878353","article-title":"Influence of androgen deprivation therapy on the PD-L1 expression and immune activity in prostate cancer tissue","volume":"9","author":"Sommer","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.repbio.2026.101187_bib36","doi-asserted-by":"crossref","first-page":"9464","DOI":"10.1038\/s41467-024-53706-3","article-title":"Prostaglandin E(2)-EP2\/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells","volume":"15","author":"Punyawatthananukool","year":"2024","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.repbio.2026.101187_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110914","article-title":"PGE(2)-EP2\/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment","volume":"39","author":"Thumkeo","year":"2022","journal-title":"Cell Rep"},{"issue":"21","key":"10.1016\/j.repbio.2026.101187_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178644","article-title":"Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity","volume":"9","author":"Markosyan","year":"2024","journal-title":"JCI Insight"},{"issue":"7718","key":"10.1016\/j.repbio.2026.101187_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.repbio.2026.101187_bib40","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1073\/pnas.1612920114","article-title":"COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","volume":"114","author":"Prima","year":"2017","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X26000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X26000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:33:07Z","timestamp":1785843187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1642431X26000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1642431X26000094"],"URL":"https:\/\/doi.org\/10.1016\/j.repbio.2026.101187","relation":{},"ISSN":["1642-431X"],"issn-type":[{"value":"1642-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silencing fatty acid binding protein 5 inhibits prostaglandin E2 and activates CD8 T cells in castration-resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repbio.2026.101187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101187"}}